Biopharm was founded in 1992 by its visionary founder, Abdelmadjid KERRAR, who took on the ambitious challenge of investing in Algeria's pharmaceutical industry. With determination and perseverance, he embarked on a remarkable journey that has driven the company’s growth. Through strategic investments, Biopharm Laboratories has become one of the leading players in the Algerian pharmaceutical sector.
1992
2002
2003
2005
2006
2008
2014
2014
2016
2016
2017
2018
2019
2020
2021
In 2016, a significant milestone in the company's history was achieved with its listing on the stock exchange, granting it the status of an Algerian Private Investment Group. This recognition strengthened its market position and reinforced its commitment to transparency and Algeria's economic growth.
Over the years, various publications have consistently confirmed Biopharm Group's leading role both nationally and across the African continent. This acknowledgment reflects the Group’s sustained performance, evident through the quality and diversity of its products.
Equipped with state-of-the-art technology that adheres to Good Manufacturing Practices (GMP), Biopharm's dedication to operational excellence is supported by its certifications, including ISO 9001:2015, ISO 001 14, ANSM, and ISO 15197:2013. From its inception, Biopharm Group has placed rigorous emphasis on all aspects of product quality, allocating nearly 30% of its annual budget to a comprehensive global quality assurance system for medicines produced.
This substantial human and financial investment has not only enabled the Group to develop a wide range of its own generic drugs but has also earned the trust of global pharmaceutical leaders to manufacture their products under license.
Biopharm Group is strongly committed to supporting the scientific and academic community. This dedication is reflected in the establishment of numerous strategic partnerships through the signing of various agreements. These collaborations not only foster innovation in the pharmaceutical sector but also significantly contribute to advancing scientific research in Algeria.
With this commitment, Biopharm Group positions itself not only as a key economic player but also as a leader in research and development
Our R&D laboratory serves as a center of expertise, ensuring the scientific validation of every stage in the development process for products destined for production.
To accomplish these specialized tasks, our R&D laboratory leverages a comprehensive partnership program with university research centers across the country, engaging national experts in fields such as process engineering, rheology of dispersed forms, programmed release, encapsulation, and vectorization of molecules, among others.
